Sarah Boyce
Insider
First SEC filing: June 11, 2020 · Latest: June 13, 2022
Insider at
Insider transactions
0 buys (P)
3 sells (S)
Net: $-1,661,782
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 26, 2026 | CTNM | A | 19,000 | · | · | 19,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 27, 2026 | RNA | D | 165,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 300,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 200,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 400,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 425,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 300,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 386,015 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 474,861 | · | · | 0 Direct | -100.00% | Disposed | |
| Jan. 21, 2026 | RNA | S 10b5-1 | 6,394 | $72.45 | $463,245 | 277,000 Direct | -2.26% | Disposed | |
| Jan. 21, 2026 | RNA | S 10b5-1 | 7,993 | $72.45 | $579,093 | 269,007 Direct | -2.89% | Disposed | |
| Jan. 7, 2026 | RNA | S 10b5-1 | 8,576 | $72.23 | $619,444 | 283,394 Direct | -2.94% | Disposed | |
| Dec. 18, 2025 | RNA | G | 29,159 | · | · | 291,970 Direct | -9.08% | Disposed | |
| Dec. 17, 2025 | RNA | A | 31,000 | · | · | 336,871 Direct | +10.13% | Acquired | |
| Dec. 17, 2025 | RNA | F | 15,742 | $71.87 | $1,131,378 | 321,129 Direct | -4.67% | Disposed | |
| Sept. 5, 2025 | RNA | M 10b5-1 | 50,000 | $1.24 | $62,000 | 355,871 Direct | +16.35% | Acquired | |
| Sept. 5, 2025 | RNA | S 10b5-1 | 50,000 | $49.95 | $2,497,500 | 305,871 Direct | -14.05% | Disposed | |
| Sept. 5, 2025 | RNA | M 10b5-1 | 50,000 | · | · | 1,022,015 Direct | -4.66% | Disposed | |
| Aug. 28, 2025 | RNA | M 10b5-1 | 25,000 | $1.24 | $31,000 | 330,871 Direct | +8.17% | Acquired | |
| Aug. 28, 2025 | RNA | S 10b5-1 | 25,000 | $49.39 | $1,234,750 | 305,871 Direct | -7.56% | Disposed | |
| Aug. 28, 2025 | RNA | M 10b5-1 | 25,000 | · | · | 1,072,015 Direct | -2.28% | Disposed | |
| June 26, 2025 | CTNM | A | 14,750 | · | · | 14,750 Direct | · | Acquired | (price as of 2026-10-05) |
| March 20, 2025 | RNA | S 10b5-1 | 31,540 | $31.06 | $979,632 | 305,871 Direct | -9.35% | Disposed | |
| Jan. 21, 2025 | RNA | S 10b5-1 | 4,738 | $28.59 | $135,459 | 343,070 Direct | -1.36% | Disposed | |
| Jan. 21, 2025 | RNA | S 10b5-1 | 5,659 | $28.59 | $161,791 | 337,411 Direct | -1.65% | Disposed | |
| Jan. 6, 2025 | RNA | A | 82,500 | · | · | 347,808 Direct | +31.10% | Acquired | |
| Jan. 6, 2025 | RNA | A | 165,000 | · | · | 165,000 Direct | · | Acquired | |
| Dec. 18, 2024 | RNA | S 10b5-1 | 31,855 | $32.66 | $1,040,384 | 265,308 Direct | -10.72% | Disposed | |
| Sept. 23, 2024 | RNA | S 10b5-1 | 32,880 | $44.00 | $1,446,720 | 234,663 Direct | -12.29% | Disposed | |
| Sept. 19, 2024 | RNA | A | 62,500 | · | · | 267,543 Direct | +30.48% | Acquired | |
| Sept. 19, 2024 | RNA | A | 62,500 | · | · | 297,163 Direct | +26.63% | Acquired | |
| Aug. 6, 2024 | RNA | M 10b5-1 | 28,000 | $1.24 | $34,720 | 233,043 Direct | +13.66% | Acquired | |
| Aug. 6, 2024 | RNA | S 10b5-1 | 28,000 | $43.35 | $1,213,800 | 205,043 Direct | -12.01% | Disposed | |
| Aug. 6, 2024 | RNA | M 10b5-1 | 28,000 | · | · | 461,015 Direct | -5.73% | Disposed | |
| July 9, 2024 | RNA | M 10b5-1 | 28,000 | $1.24 | $34,720 | 233,043 Direct | +13.66% | Acquired | |
| July 9, 2024 | RNA | S 10b5-1 | 28,000 | $39.93 | $1,118,040 | 205,043 Direct | -12.01% | Disposed | |
| July 9, 2024 | RNA | M 10b5-1 | 28,000 | · | · | 489,015 Direct | -5.42% | Disposed | |
| June 24, 2024 | CTNM | A | 29,500 | · | · | 29,500 Direct | · | Acquired | (price as of 2026-10-05) |
| June 18, 2024 | OABIW | M | 20,000 | · | · | 68,381 Direct | +41.34% | Acquired | (price as of 2026-10-05) |
| June 18, 2024 | OABIW | M | 20,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| June 18, 2024 | OABIW | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 18, 2024 | OABIW | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 18, 2024 | RNA | S 10b5-1 | 32,074 | $39.13 | $1,255,056 | 142,543 Direct | -18.37% | Disposed | |
| June 17, 2024 | RNA | A | 62,500 | · | · | 174,617 Direct | +55.75% | Acquired | |
| June 17, 2024 | RNA | A | 62,500 | · | · | 205,043 Direct | +43.85% | Acquired | |
| June 14, 2024 | RNA | M 10b5-1 | 35,767 | $1.24 | $44,351 | 147,884 Direct | +31.90% | Acquired | |
| June 14, 2024 | RNA | S 10b5-1 | 35,767 | $40.08 | $1,433,541 | 112,117 Direct | -24.19% | Disposed | |
| June 14, 2024 | RNA | M 10b5-1 | 35,767 | · | · | 517,015 Direct | -6.47% | Disposed | |
| June 13, 2024 | RNA | M 10b5-1 | 164,233 | $1.24 | $203,649 | 276,350 Direct | +146.48% | Acquired | |
| June 13, 2024 | RNA | S 10b5-1 | 164,233 | $40.08 | $6,582,459 | 112,117 Direct | -59.43% | Disposed | |
| June 13, 2024 | RNA | M 10b5-1 | 164,233 | · | · | 552,782 Direct | -22.91% | Disposed | |
| June 12, 2024 | RNA | M 10b5-1 | 100,000 | $1.24 | $124,000 | 212,117 Direct | +89.19% | Acquired | |
| June 12, 2024 | RNA | S 10b5-1 | 100,000 | $35.73 | $3,573,000 | 112,117 Direct | -47.14% | Disposed | |
| June 12, 2024 | RNA | M 10b5-1 | 100,000 | · | · | 717,015 Direct | -12.24% | Disposed | |
| June 4, 2024 | RNA | M 10b5-1 | 28,000 | $1.24 | $34,720 | 140,117 Direct | +24.97% | Acquired | |
| June 4, 2024 | RNA | S 10b5-1 | 28,000 | $27.42 | $767,760 | 112,117 Direct | -19.98% | Disposed | |
| June 4, 2024 | RNA | M 10b5-1 | 28,000 | · | · | 817,015 Direct | -3.31% | Disposed | |
| May 7, 2024 | RNA | M 10b5-1 | 28,000 | $1.24 | $34,720 | 140,117 Direct | +24.97% | Acquired | |
| May 7, 2024 | RNA | S 10b5-1 | 28,000 | $25.54 | $715,120 | 112,117 Direct | -19.98% | Disposed | |
| May 7, 2024 | RNA | M 10b5-1 | 28,000 | · | · | 845,015 Direct | -3.21% | Disposed | |
| April 2, 2024 | RNA | M 10b5-1 | 28,000 | $1.24 | $34,720 | 140,117 Direct | +24.97% | Acquired | |
| April 2, 2024 | RNA | S 10b5-1 | 28,000 | $26.25 | $735,000 | 112,117 Direct | -19.98% | Disposed | |
| April 2, 2024 | RNA | M 10b5-1 | 28,000 | · | · | 873,015 Direct | -3.11% | Disposed | |
| March 12, 2024 | RNA | M 10b5-1 | 28,000 | $1.24 | $34,720 | 140,117 Direct | +24.97% | Acquired | |
| March 12, 2024 | RNA | S 10b5-1 | 28,000 | $22.63 | $633,640 | 112,117 Direct | -19.98% | Disposed | |
| March 12, 2024 | RNA | M 10b5-1 | 28,000 | · | · | 901,015 Direct | -3.01% | Disposed | |
| March 8, 2024 | RNA | M 10b5-1 | 84,000 | $1.24 | $104,160 | 196,117 Direct | +74.92% | Acquired | |
| March 8, 2024 | RNA | S 10b5-1 | 84,000 | $21.39 | $1,796,760 | 112,117 Direct | -42.83% | Disposed | |
| March 8, 2024 | RNA | M 10b5-1 | 84,000 | · | · | 929,015 Direct | -8.29% | Disposed | |
| March 1, 2024 | RNA | M 10b5-1 | 84,000 | $1.24 | $104,160 | 196,117 Direct | +74.92% | Acquired | |
| March 1, 2024 | RNA | S 10b5-1 | 84,000 | $20.13 | $1,690,920 | 112,117 Direct | -42.83% | Disposed | |
| March 1, 2024 | RNA | M 10b5-1 | 84,000 | · | · | 1,013,015 Direct | -7.66% | Disposed | |
| Jan. 22, 2024 | RNA | S 10b5-1 | 5,092 | $10.13 | $51,582 | 44,008 Direct | -10.37% | Disposed | |
| Jan. 20, 2024 | RNA | A | 62,500 | · | · | 67,209 Direct | +1327.25% | Acquired | |
| Jan. 20, 2024 | RNA | A | 300,000 | · | · | 300,000 Direct | · | Acquired | |
| Sept. 11, 2023 | RNA | A | 200,000 | · | · | 200,000 Direct | · | Acquired | |
| June 23, 2023 | OABIW | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 23, 2023 | OABIW | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 3, 2023 | RNA | M 10b5-1 | 3,221 | · | · | 1,097,015 Direct | -0.29% | Disposed | |
| Feb. 3, 2023 | RNA | S 10b5-1 | 3,221 | $24.26 | $78,141 | 53,352 Direct | -5.69% | Disposed | |
| Feb. 3, 2023 | RNA | M 10b5-1 | 3,221 | $1.24 | $3,994 | 56,573 Direct | +6.04% | Acquired | |
| Feb. 2, 2023 | RNA | M 10b5-1 | 45,879 | · | · | 1,100,236 Direct | -4.00% | Disposed | |
| Feb. 2, 2023 | RNA | S 10b5-1 | 45,879 | $24.36 | $1,117,612 | 53,352 Direct | -46.23% | Disposed | |
| Feb. 2, 2023 | RNA | M 10b5-1 | 45,879 | $1.24 | $56,890 | 99,231 Direct | +85.99% | Acquired | |
| Feb. 1, 2023 | RNA | M 10b5-1 | 900 | · | · | 1,146,115 Direct | -0.08% | Disposed | |
| Feb. 1, 2023 | RNA | S 10b5-1 | 900 | $24.27 | $21,843 | 53,352 Direct | -1.66% | Disposed | |
| Feb. 1, 2023 | RNA | M 10b5-1 | 900 | $1.24 | $1,116 | 54,252 Direct | +1.69% | Acquired | |
| Jan. 30, 2023 | OABIW | A | 8,753 | · | · | 46,190 Direct | +23.38% | Acquired | (price as of 2026-10-05) |
| Jan. 30, 2023 | OABIW | A | 37,840 | · | · | 37,840 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 20, 2023 | RNA | A | 400,000 | · | · | 400,000 Direct | · | Acquired | |
| Jan. 20, 2023 | RNA | A | 50,000 | · | · | 53,352 Direct | +1491.65% | Acquired | |
| Nov. 10, 2022 | OABIW | P | 15,000 | $2.92 | $43,800 | 36,000 Indirect | +71.43% | Acquired | -86.6% (price as of 2026-10-05) |
| Nov. 9, 2022 | OABIW | P | 21,000 | $2.74 | $57,540 | 21,000 Indirect | · | Acquired | -85.8% (price as of 2026-10-05) |
| Nov. 1, 2022 | OABIW | A | 39,628 | · | · | 48,381 Direct | +452.74% | Acquired | (price as of 2026-10-05) |
| Nov. 1, 2022 | OABIW | A | 37,840 | · | · | 37,840 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 1, 2022 | OABIW | A | 13,994 | · | · | 13,994 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 1, 2022 | OABIW | A | 10,565 | · | · | 10,565 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 1, 2022 | OABIW | A | 22,616 | · | · | 22,616 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 1, 2022 | OABIW | A | 37,437 | · | · | 37,437 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 1, 2022 | LGND | D | 4,340 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
Showing latest 100 of 145 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 26, 2026 | CTNM | Stock Option (right to buy) | Class A Common Stock | $14.19 | June 25, 2036 | 19,000 | Acquired |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $31.42 | Jan. 5, 2035 | 165,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $10.16 | Jan. 19, 2034 | 300,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $6.57 | Sept. 10, 2033 | 200,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $22.47 | Jan. 19, 2033 | 400,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $14.22 | Jan. 20, 2032 | 425,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $22.34 | Feb. 1, 2031 | 300,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 386,015 | Disposed |
| Sept. 5, 2025 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 50,000 | Disposed |
| Aug. 28, 2025 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 25,000 | Disposed |
| June 26, 2025 | CTNM | Stock Option (right to buy) | Class A Common Stock | $4.01 | June 25, 2035 | 14,750 | Acquired |
| Jan. 6, 2025 | RNA | Stock Option (Right to Buy) | Common Stock | $31.42 | Jan. 5, 2035 | 165,000 | Acquired |
| Aug. 6, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 28,000 | Disposed |
| July 9, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 28,000 | Disposed |
| June 24, 2024 | CTNM | Stock Option (right to buy) | Class A Common Stock | $19.19 | June 23, 2034 | 29,500 | Acquired |
| June 18, 2024 | OABIW | Restricted Stock Units | Common Stock | · | · | 20,000 | Disposed |
| June 18, 2024 | OABIW | Restricted Stock Units | Common Stock | · | · | 20,000 | Acquired |
| June 18, 2024 | OABIW | Stock Option (right to buy) | Common Stock | $4.19 | June 18, 2034 | 40,000 | Acquired |
| June 14, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 35,767 | Disposed |
| June 13, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 164,233 | Disposed |
| June 12, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 100,000 | Disposed |
| June 4, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 28,000 | Disposed |
| May 7, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 28,000 | Disposed |
| April 2, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 28,000 | Disposed |
| March 12, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 28,000 | Disposed |
| March 8, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 84,000 | Disposed |
| March 1, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 84,000 | Disposed |
| Jan. 20, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $10.16 | Jan. 19, 2034 | 300,000 | Acquired |
| Sept. 11, 2023 | RNA | Stock Option (Right to Buy) | Common Stock | $6.57 | Sept. 10, 2033 | 200,000 | Acquired |
| June 23, 2023 | OABIW | Restricted Stock Units | Common Stock | · | · | 20,000 | Acquired |
| June 23, 2023 | OABIW | Stock Option (right to buy) | Common Stock | $4.81 | June 23, 2033 | 40,000 | Acquired |
| Feb. 3, 2023 | RNA | Stock Option (Right to | Common Stock | $1.24 | Dec. 17, 2029 | 3,221 | Disposed |
| Feb. 2, 2023 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 45,879 | Disposed |
| Feb. 1, 2023 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 900 | Disposed |
| Jan. 30, 2023 | OABIW | Stock Option | Common Stock | $4.25 | Jan. 30, 2033 | 37,840 | Acquired |
| Jan. 20, 2023 | RNA | Stock Option (Right to Buy) | Common Stock | $22.47 | Jan. 19, 2033 | 400,000 | Acquired |
| Nov. 1, 2022 | OABIW | Stock Option | Common Stock | $9.10 | June 10, 2032 | 37,840 | Acquired |
| Nov. 1, 2022 | OABIW | Stock Option | Common Stock | $13.24 | June 4, 2031 | 13,994 | Acquired |
| Nov. 1, 2022 | OABIW | Stock Option | Common Stock | $13.49 | June 10, 2030 | 10,565 | Acquired |
| Nov. 1, 2022 | OABIW | Stock Option | Common Stock | $12.37 | Oct. 15, 2029 | 22,616 | Acquired |
| Nov. 1, 2022 | LGND | Employee Stock Option (right to buy) | Common Stock | $90.68 | June 10, 2032 | 4,340 | Disposed |
| Aug. 25, 2022 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 14,855 | Disposed |
| Aug. 24, 2022 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 35,045 | Disposed |
| Aug. 15, 2022 | RNA | Stock Option (Right to Buy) | Common Stock | $1.24 | Dec. 17, 2029 | 100 | Disposed |
| June 10, 2022 | LGND | Non-Qualified Stock Option (right to buy) | Common Stock | $79.29 | June 10, 2032 | 4,340 | Acquired |
| Jan. 21, 2022 | RNA | Stock Option (Right to Buy) | Common Stock | $14.22 | Jan. 20, 2032 | 425,000 | Acquired |
| June 4, 2021 | LGND | Non-Qualified Stock Option (right to buy) | Common Stock | $115.39 | June 4, 2031 | 3,269 | Acquired |
| Feb. 2, 2021 | RNA | Stock Option (Right to Buy) | Common Stock | $22.34 | Feb. 1, 2031 | 300,000 | Acquired |
| June 10, 2020 | LGND | Non-Qualified Stock Option (right to buy) | Common Stock | $117.58 | June 10, 2030 | 2,468 | Acquired |
| Oct. 15, 2019 | LGND | Non-Qualified Stock Option (right to buy) | Common Stock | $107.81 | Oct. 15, 2029 | 5,283 | Acquired |
| Jan. 15, 2018 | IONS | Restricted Stock Units | Common Stock | · | · | 5,367 | Disposed |
| Jan. 15, 2018 | IONS | Restricted Stock Units | Common Stock | · | · | 12,916 | Acquired |
| Jan. 2, 2018 | IONS | Employee Stock Option (right to buy) | Common Stock | $49.25 | Jan. 1, 2025 | 58,125 | Acquired |
| Jan. 15, 2017 | IONS | Restricted Stock Units | Common Stock | · | · | 1,295 | Disposed |
| Jan. 15, 2017 | IONS | Restricted Stock Units | Common Stock | · | · | 2,188 | Disposed |
| Jan. 15, 2017 | IONS | Restricted Stock Units | Common Stock | · | · | 7,537 | Acquired |
| Jan. 3, 2017 | IONS | Employee Stock Option (right to buy) | Common Stock | $47.34 | Jan. 2, 2024 | 45,225 | Acquired |
| Jan. 15, 2016 | IONS | Restricted Stock Units | Common Stock | · | · | 2,188 | Disposed |
| Jan. 15, 2016 | IONS | Restricted Stock Units | Common Stock | · | · | 5,178 | Acquired |
| Jan. 4, 2016 | IONS | Employee Stock Option (right to buy) | Common Stock | $61.68 | Jan. 3, 2023 | 31,070 | Acquired |
| Jan. 15, 2015 | IONS | Restricted Stock Units | Common Stock | · | · | 8,750 | Acquired |
| Jan. 1, 2015 | IONS | Employee Stock Option (right to buy) | Common Stock | $61.74 | Dec. 31, 2021 | 52,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 11, 2020 | RNA | Stock Option (Right to Buy) | 1,197,015 | Direct |
| Jan. 5, 2015 | IONS | No Securities Owned | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CIK 1599901
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $659,900 | · | $10,748,480 | $2,157,090 | $594,000 | · | $17,010 | $14,176,480 |
| 2023 | $634,500 | · | $10,140,840 | · | $349,000 | · | $15,379 | $11,139,719 |
| 2022 | $601,400 | · | · | · | $430,100 | · | $15,336 | $5,366,111 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.